SEC 13F Intelligence

Boston Family Office LLC / TMO

Boston Family Office LLC’s Thermo Fisher Scientific Inc Position

Does Boston Family Office LLC own Thermo Fisher Scientific Inc (TMO)? Yes — 40.3K shares worth $20M (+1.32% of its 13F portfolio) as of Q1 2026, up from 40.1K shares the prior filed quarter.

Position Value
$20M
Q1 2026
Shares
40.3K
% of Portfolio
+1.32%
Quarters Held
29
currently held

Position History TMO

Reported value by quarter
Q1 ’19: $10MQ1 ’19Q2 ’19: $11MQ3 ’19: $11MQ4 ’19: $12MQ1 ’20: $10MQ1 ’20Q2 ’20: $14MQ3 ’20: $17MQ4 ’20: $17MQ1 ’21: $17MQ1 ’21Q2 ’21: $19MQ3 ’21: $22MQ4 ’21: $25MQ1 ’22: $22MQ1 ’22Q2 ’22: $20MQ3 ’22: $20MQ4 ’22: $21MQ1 ’23: $22MQ1 ’23Q2 ’23: $20MQ3 ’23: $19MQ4 ’23: $20MQ1 ’24: $22MQ1 ’24Q2 ’24: $22MQ3 ’24: $25MQ4 ’24: $21MQ1 ’25: $20MQ1 ’25Q2 ’25: $17MQ3 ’25: $20MQ4 ’25: $23MQ1 ’26: $20MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202640.3K$20M+1.32%
Q4 202540.1K$23M+1.47%
Q3 202541.0K$20M+1.26%
Q2 202541.2K$17M+1.11%
Q1 202540.0K$20M+1.41%
Q4 202440.2K$21M+1.44%
Q3 202440.5K$25M+1.70%
Q2 202440.2K$22M+1.60%
Q1 202438.4K$22M+1.61%
Q4 202338.4K$20M+1.53%
Q3 202337.7K$19M+1.56%
Q2 202337.7K$20M+1.51%
Q1 202337.7K$22M+1.74%
Q4 202238.8K$21M+1.77%
Q3 202240.0K$20M+1.80%
Q2 202237.3K$20M+1.69%
Q1 202236.6K$22M+1.54%
Q4 202137.4K$25M+1.62%
Q3 202137.6K$22M+1.56%
Q2 202137.4K$19M+1.34%
Q1 202137.2K$17M+1.28%
Q4 202037.5K$17M+1.34%
Q3 202037.5K$17M+1.50%
Q2 202037.7K$14M+1.33%
Q1 202036.8K$10M+1.23%
Q4 201936.6K$12M+1.13%
Q3 201936.8K$11M+1.11%
Q2 201936.8K$11M+1.12%
Q1 201936.6K$10M+1.08%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Boston Family Office LLC’s full portfolio or all institutional holders of TMO.